Global Health Otherwise shared a post on LinkedIn:
“How Is the World Fighting Vaccine-Preventable Diseases in 2025?
Every year, millions of people die from diseases that vaccines could prevent. This problem hits hardest in poorer countries, where access to affordable vaccines remains limited.
Against this backdrop, the International Vaccine Institute (IVI) released its 2025 Annual Report, documenting its global efforts to change this reality.
The report covers IVI’s work across more than 50 projects in Africa alone, targeting diseases like cholera, typhoid, mpox, and schistosomiasis. IVI began developing its fourth in-house vaccine, targeting Klebsiella pneumoniae, the leading cause of neonatal sepsis worldwide.
The organization launched an mpox vaccine study in the Democratic Republic of Congo, aiming to vaccinate 150,000 people. In Burkina Faso, a typhoid vaccination campaign reached over 10 million children. IVI also trained thousands of biomanufacturing professionals globally, building local capacity in low and middle income countries.
The report reveals a clear institutional commitment: vaccines must reach the people who need them most, not just those who can afford them.
𝗜𝗩𝗜’𝘀 𝟮𝟬𝟮𝟱 𝗔𝗻𝗻𝘂𝗮𝗹 𝗥𝗲𝗽𝗼𝗿𝘁 𝗱𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝘀 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁, 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀, 𝗮𝗻𝗱 𝘁𝗿𝗮𝗶𝗻𝗶𝗻𝗴 𝗽𝗿𝗼𝗴𝗿𝗮𝗺𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝗹𝗼𝘄 𝗮𝗻𝗱 𝗺𝗶𝗱𝗱𝗹𝗲 𝗶𝗻𝗰𝗼𝗺𝗲 𝗰𝗼𝘂𝗻𝘁𝗿𝗶𝗲𝘀, 𝗮𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗴𝗹𝗼𝗯𝗮𝗹 𝗵𝗲𝗮𝗹𝘁𝗵 𝗲𝗾𝘂𝗶𝘁𝘆 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝘀𝗰𝗶𝗲𝗻𝗰𝗲, 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀, 𝗮𝗻𝗱 𝗹𝗼𝗰𝗮𝗹 𝗰𝗮𝗽𝗮𝗰𝗶𝘁𝘆 𝗯𝘂𝗶𝗹𝗱𝗶𝗻𝗴.”
Other articles featuring Global Health Otherwise on OncoDaily.